We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
10 Year Est. Return
AUM
$1.04B
AUM Growth
+$73.9M
Cap. Flow
-$29.1M
Cap. Flow %
-2.79%
Top 10 Hldgs %
15.75%
Holding
360
New
39
Increased
72
Reduced
129
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Technology 24.11%
3 Consumer Discretionary 12.45%
4 Industrials 11.51%
5 Communication Services 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGI
101
DELISTED
Celadon Group Inc
CGI
$3.29M 0.32%
144,900
XLRN
102
DELISTED
Acceleron Pharma
XLRN
$3.22M 0.31%
82,700
-500
-0.6% -$17.4K
SIEN
103
DELISTED
Sientra, Inc.
SIEN
$3.16M 0.3%
+18,840
New +$3.21M
EGRX
104
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.1M 0.3%
200,000
BAS
105
DELISTED
Basis Energy Services, Inc.
BAS
$3.07M 0.29%
767
-10
-1% -$63.1K
MDSO
106
DELISTED
Medidata Solutions, Inc.
MDSO
$3.06M 0.29%
64,180
-3,316
-5% -$144K
OXFD
107
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.03M 0.29%
222,400
-8,800
-4% -$120K
FLXN
108
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3.03M 0.29%
150,000
BRDR
109
DELISTED
BODERFREE INC COM
BRDR
$3.02M 0.29%
336,477
-234,623
-41% -$2.25M
WAGE
110
DELISTED
WageWorks, Inc.
WAGE
$3.01M 0.29%
46,661
-2,967
-6% -$165K
DARE icon
111
Dare Bioscience
DARE
$21M
$2.95M 0.28%
3,958
NUWE icon
112
Nuwellis
NUWE
$543K
0
NEOG icon
113
Neogen
NEOG
$2.5B
$2.87M 0.28%
154,427
+47,739
+45% +$785K
TVRD
114
Tvardi Therapeutics
TVRD
$23.4M
$2.86M 0.27%
7,975
PCRX icon
115
Pacira BioSciences
PCRX
$997M
$2.83M 0.27%
31,883
-2,207
-6% -$209K
WAB icon
116
Wabtec
WAB
$49.3B
$2.8M 0.27%
32,177
-2,320
-7% -$195K
WNS
117
DELISTED
WNS Holdings
WNS
$2.77M 0.27%
134,261
-58,339
-30% -$1.22M
TEAR
118
DELISTED
TearLab Corporation
TEAR
$2.77M 0.27%
104,670
SAM icon
119
Boston Beer
SAM
$1.92B
$2.75M 0.26%
9,485
-632
-6% -$160K
SGYP
120
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.73M 0.26%
894,800
VSTM icon
121
Verastem
VSTM
$610M
$2.69M 0.26%
24,508
-175
-0.7% -$18.9K
AKRX
122
DELISTED
Akorn Inc
AKRX
$2.67M 0.26%
73,757
-27,504
-27% -$1.06M
ATRC icon
123
AtriCure
ATRC
$2.11B
$2.62M 0.25%
131,347
+50
+0% +$858
AVNT icon
124
Avient
AVNT
$4.19B
$2.62M 0.25%
69,100
-3,891
-5% -$142K
EXAM
125
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$2.61M 0.25%
62,854
-10,519
-14% -$401K

Similar funds

Wall Street Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Wall Street Associates held 360 positions worth $1.04B, up 7.6% from $969M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wall Street Associates's Q4 2014 filing shows 39 new, 72 increased, 129 reduced and 44 closed positions. Its largest new stake was Neff Corporation: 688,800 shares worth $7.76M. The largest sale was MOVE INC COM STK NEW (DE), an estimated $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Wall Street Associates's largest Q4 2014 buy was Neff Corporation: 688,800 shares worth $7.76M.
  • Wall Street Associates added most to Christopher & Banks Corporation in Q4 2014, an estimated $2.24M increase.
  • Wall Street Associates's biggest Q4 2014 reduction was Spectranetics Corp, cutting an estimated $16.5M.
  • Wall Street Associates fully exited MOVE INC COM STK NEW (DE) in Q4 2014, selling an estimated $17.7M.
  • Wall Street Associates's ten largest holdings make up 16% of its $1.04B portfolio in Q4 2014.
  • Wall Street Associates opened 39 new positions and closed 44 in Q4 2014.
  • Wall Street Associates's portfolio value rose 7.6% quarter-over-quarter to $1.04B.

Based on Wall Street Associates's 13F filing for Q4 2014, filed 12 Feb 2015.